September 17, 2025 · Form 4 insider transaction
Halladay Benjamin sold 7,046 shares of Esperion Therapeutics, Inc. Common Stock at $2.81 per share, a transaction worth $19.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Shares were sold to satisfy tax obligation on vested shares of restricted stock units.; Includes 7,446 shares recently acquired in Esperion's Employee Stock Purchase Plan.